|
|
Previous Article | Table of Contents | Next Article 
Enhanced detection, maintenance, and differentiation of primitive human
hematopoietic cells in cultures containing murine fibroblasts engineered to
produce human steel factor, interleukin-3, and granulocyte
colony-stimulating factor
DE Hogge, PM Lansdorp, D Reid, B Gerhard and CJ Eaves
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada.
To determine whether the sensitivity of the human long-term culture-
initiating cell (LTC-IC) assay could be increased, we have evaluated a
spectrum of different fibroblast cell lines for their abilities to
influence the number of cells detectable as LTC-IC, to influence LTC-IC
maintenance, and/or to influence LTC-IC differentiation into colony-
forming cells (CFC) in cocultures containing various sources of LTC-IC. In
a series of initial experiments with highly purified subpopulations of
CD34+ cells from normal human marrow, no significant difference could be
found between any of 3 different murine stromal fibroblast cells in terms
of their support of either LTC-IC detection (CFC production) or maintenance
(over a 6-week period), and all were equivalent to primary human marrow
feeders (HMF). On the other hand, murine M2-10B4 fibroblasts engineered to
produce high levels of both human granulocyte colony-stimulating factor
(G-CSF) and interleukin-3 (IL-3; 190 and 4 ng/mL, respectively), either
alone or mixed 1:1 with SI/SI fibroblasts engineered to produce high levels
of soluble Steel factor (SF), with or without production of the
transmembrane form of SF (60 and 4 ng/ mL, respectively), stimulated the
production of up to 20- fold more CFC in LTC of cells from normal human
marrow, G-CSF-mobilized blood or cord blood when compared with parallel
cocultures containing HMF. Limiting dilution analysis of the CFC output
from all three sources of LTC-IC showed that most of this increase was due
to an ability of the engineered feeders to increase the plating efficiency
of the LTC-IC assay (approximately 14-fold for marrow LTC-IC and
approximately 4-fold for cord blood or mobilized blood LTC-IC). Analysis of
the phenotype of these additionally recruited LTC-IC from marrow showed
they had the same primitive CD34+CD45RA-CD71- phenotype as conventionally
defined LTC-IC. The limiting dilution studies also showed that the average
number of CFC produced per LTC-IC was additionally and independently
increased to yield values of 18 CFC per LTC-IC in marrow, 28 for LTC-IC in
cord blood, and 25 for LTC-IC in G- CSF-mobilized blood. Replating of cells
from primary LTC with different feeders into secondary LTC-IC assays
containing the best combination of engineered feeders showed that LTC-IC
maintenance could be significantly enhanced (up to 7-fold as compared with
primary cocultures containing HMF). However, this enhancement was still not
sufficient to amplify the number of LTC-IC present after 6 weeks above the
input value. Thus, engineering murine fibroblasts to produce sufficient SF,
G-CSF, and IL-3 can markedly enhance the detection as well as the
maintenance in vitro of a very primitive population of human progenitor
cells present in normal adult marrow, mobilized blood, and cord blood by
providing the most sensitive assay conditions thus far described. The
present findings also provide new evidence of biologic heterogeneity
between different cell populations that can be operationally identified as
LTC-IC, thus re-emphasizing the importance of limiting dilution analyses to
distinguish between quantitative and qualitative effects on these cells.
Volume 88,
Issue 10,
pp. 3765-3773,
11/15/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Tipping, C. Pina, A. Castor, D. Hong, N. P. Rodrigues, L. Lazzari, G. E. May, S. E. W. Jacobsen, and T. Enver
High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle
Blood,
March 19, 2009;
113(12):
2661 - 2672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D. Goldman, G. Aubert, A. J. Klingelhutz, M. Hills, S. R. Cooper, W. S. Hamilton, A. J. Schlueter, K. Lambie, C. J. Eaves, and P. M. Lansdorp
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita
Blood,
May 1, 2008;
111(9):
4523 - 4531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Mrugala, C Bony, N Neves, L Caillot, S Fabre, D Moukoko, C Jorgensen, and D Noel
Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model
Ann Rheum Dis,
March 1, 2008;
67(3):
288 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Copland, F. Pellicano, L. Richmond, E. K. Allan, A. Hamilton, F. Y. Lee, R. Weinmann, and T. L. Holyoake
BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors
Blood,
March 1, 2008;
111(5):
2843 - 2853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Christ, K. Lucke, S. Imren, K. Leung, M. Hamilton, A. Eaves, C. Smith, and C. Eaves
Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity
Haematologica,
September 1, 2007;
92(9):
1165 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Goodrum, M. Reeves, J. Sinclair, K. High, and T. Shenk
Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro
Blood,
August 1, 2007;
110(3):
937 - 945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Jiang, K. M. Saw, A. Eaves, and C. Eaves
Instability of BCR-ABL Gene in Primary and Cultured Chronic Myeloid Leukemia Stem Cells
J Natl Cancer Inst,
May 2, 2007;
99(9):
680 - 693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yalcintepe, A. E. Frankel, and D. E. Hogge
Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice
Blood,
November 15, 2006;
108(10):
3530 - 3537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Takeda, C. Goolsby, and N. R. Yaseen
NUP98-HOXA9 Induces Long-term Proliferation and Blocks Differentiation of Primary Human CD34+ Hematopoietic Cells.
Cancer Res.,
July 1, 2006;
66(13):
6628 - 6637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Hogge, L. Yalcintepe, S.-H. Wong, B. Gerhard, and A. E. Frankel
Variant Diphtheria Toxin-Interleukin-3 Fusion Proteins with Increased Receptor Affinity Have Enhanced Cytotoxicity against Acute Myeloid Leukemia Progenitors
Clin. Cancer Res.,
February 15, 2006;
12(4):
1284 - 1291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, I. Dybedal, D. Bryder, L. Nilsson, E. Sitnicka, Y. Sasaki, and S. E. W. Jacobsen
IFN-{gamma} Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells
J. Immunol.,
January 15, 2005;
174(2):
752 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Vercauteren and H. J. Sutherland
Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo
Blood,
October 15, 2004;
104(8):
2315 - 2322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Thanopoulou, J. Cashman, T. Kakagianne, A. Eaves, N. Zoumbos, and C. Eaves
Engraftment of NOD/SCID-{beta}2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome
Blood,
June 1, 2004;
103(11):
4285 - 4293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Jiang, Y. Zhao, W.-Y. Chan, S. Vercauteren, E. Pang, S. Kennedy, F. Nicolini, A. Eaves, and C. Eaves
Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia
Blood,
May 15, 2004;
103(10):
3897 - 3904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Mulloy, J. Cammenga, F. J. Berguido, K. Wu, P. Zhou, R. L. Comenzo, S. Jhanwar, M. A. S. Moore, and S. D. Nimer
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element
Blood,
December 15, 2003;
102(13):
4369 - 4376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sitnicka, N. Buza-Vidas, S. Larsson, J. M. Nygren, K. Liuba, and S. E. W. Jacobsen
Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells
Blood,
August 1, 2003;
102(3):
881 - 886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, L. Yang, D. Bryder, I. Aastrand-Grundstrom, K. Leandersson, and S. E. W. Jacobsen
Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
Blood,
July 1, 2003;
102(1):
118 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cashman, B. Dykstra, I. Clark-Lewis, A. Eaves, and C. Eaves
Changes in the Proliferative Activity of Human Hematopoietic Stem Cells in NOD/SCID Mice and Enhancement of Their Transplantability after In Vivo Treatment with Cell Cycle Inhibitors
J. Exp. Med.,
November 4, 2002;
196(9):
1141 - 1150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bug, T. Rossmanith, R. Henschler, L.A. Kunz-Schughart, B. Schroder, M. Kampfmann, M. Kreutz, D. Hoelzer, and O. G. Ottmann
Rho family small GTPases control migration of hematopoietic progenitor cells into multicellular spheroids of bone marrow stroma cells
J. Leukoc. Biol.,
October 1, 2002;
72(4):
837 - 845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Danet, J. L. Luongo, G. Butler, M. M. Lu, A. J. Tenner, M. C. Simon, and D. A. Bonnet
C1qRp defines a new human stem cell population with hematopoietic and hepatic potential
PNAS,
August 6, 2002;
99(16):
10441 - 10445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Nicolini, S. Imren, I.-H. Oh, R. K. Humphries, P. Leboulch, M. E. Fabry, R. L. Nagel, and C. J. Eaves
Expression of a human beta -globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells
Blood,
July 30, 2002;
100(4):
1257 - 1264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Buske, M. Feuring-Buske, C. Abramovich, K. Spiekermann, C. J. Eaves, L. Coulombel, G. Sauvageau, D. E. Hogge, and R. K. Humphries
Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells
Blood,
July 18, 2002;
100(3):
862 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Nilsson, I. Astrand-Grundstrom, K. Anderson, I. Arvidsson, P. Hokland, D. Bryder, L. Kjeldsen, B. Johansson, E. Hellstrom-Lindberg, R. Hast, et al.
Involvement and functional impairment of the CD34+CD38-Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8
Blood,
June 17, 2002;
100(1):
259 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Manchester, K. A. Smith, D. S. Eto, H. B. Perkin, and B. E. Torbett
Targeting and Hematopoietic Suppression of Human CD34+ Cells by Measles Virus
J. Virol.,
June 5, 2002;
76(13):
6636 - 6642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chalandon, X. Jiang, G. Hazlewood, S. Loutet, E. Conneally, A. Eaves, and C. Eaves
Modulation of p210BCR-ABL activity in transduced primary human hematopoietic cells controls lineage programming
Blood,
May 1, 2002;
99(9):
3197 - 3204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Glimm, P. Tang, I. Clark-Lewis, C. von Kalle, and C. Eaves
Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD/SCID mice
Blood,
May 1, 2002;
99(9):
3454 - 3457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Feuring-Buske, A. E. Frankel, R. L. Alexander, B. Gerhard, and D. E. Hogge
A Diphtheria Toxin-Interleukin 3 Fusion Protein Is Cytotoxic to Primitive Acute Myeloid Leukemia Progenitors But Spares Normal Progenitors
Cancer Res.,
March 1, 2002;
62(6):
1730 - 1736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cashman, I. Clark-Lewis, A. Eaves, and C. Eaves
Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice
Blood,
February 1, 2002;
99(3):
792 - 799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, D. Bryder, A. Fossum, L. S. Rusten, and S. E. W. Jacobsen
Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells
Blood,
September 15, 2001;
98(6):
1782 - 1791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Feuring-Buske and D. E. Hogge
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38{-} progenitor cells from patients with acute myeloid leukemia
Blood,
June 15, 2001;
97(12):
3882 - 3889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Buske, M. Feuring-Buske, J. Antonchuk, P. Rosten, D. E. Hogge, C. J. Eaves, and R. K. Humphries
Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo
Blood,
April 15, 2001;
97(8):
2286 - 2292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Maguer-Satta, R. Oostendorp, D. Reid, and C. J. Eaves
Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates
Blood,
December 15, 2000;
96(13):
4118 - 4123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Glimm, I.-H. Oh, and C. J. Eaves
Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0
Blood,
December 15, 2000;
96(13):
4185 - 4193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hennemann, I.-H. Oh, J. Y. Chuo, C. P. Kalberer, P. D. Schley, S. Rose-John, R. K. Humphries, and C. J. Eaves
Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin
Blood,
October 1, 2000;
96(7):
2432 - 2439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Brummendorf, T. L. Holyoake, N. Rufer, M. J. Barnett, M. Schulzer, C. J. Eaves, A. C. Eaves, and P. M. Lansdorp
Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry
Blood,
March 15, 2000;
95(6):
1883 - 1890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Ramsfjell, D. Bryder, H. Bjorgvinsdottir, S. Kornfalt, L. Nilsson, O. J. Borge, and S. E.W. Jacobsen
Distinct Requirements for Optimal Growth and In Vitro Expansion of Human CD34+CD38- Bone Marrow Long-Term Culture-Initiating Cells (LTC-IC), Extended LTC-IC, and Murine In Vivo Long-Term Reconstituting Stem Cells
Blood,
December 15, 1999;
94(12):
4093 - 4102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.D. Cashman, I. Clark-Lewis, A.C. Eaves, and C.J. Eaves
Differentiation Stage-Specific Regulation of Primitive Human Hematopoietic Progenitor Cycling by Exogenous and Endogenous Inhibitors in an In Vivo Model
Blood,
December 1, 1999;
94(11):
3722 - 3729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Jiang, A. Lopez, T. Holyoake, A. Eaves, and C. Eaves
Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia
PNAS,
October 26, 1999;
96(22):
12804 - 12809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Nicolini, T. L. Holyoake, J. D. Cashman, P. P.Y. Chu, K. Lambie, and C. J. Eaves
Unique Differentiation Programs of Human Fetal Liver Stem Cells Shown Both In Vitro and In Vivo in NOD/SCID Mice
Blood,
October 15, 1999;
94(8):
2686 - 2695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Glimm and C.J. Eaves
Direct Evidence for Multiple Self-Renewal Divisions of Human In Vivo Repopulating Hematopoietic Cells in Short-Term Culture
Blood,
October 1, 1999;
94(7):
2161 - 2168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rondelli, R. M. Lemoli, M. Ratta, M. Fogli, F. Re, A. Curti, M. Arpinati, and S. Tura
Rapid Induction of CD40 on a Subset of Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Blood Cells Identifies Myeloid Committed Progenitors and Permits Selection of Nonimmunogenic CD40- Progenitor Cells
Blood,
October 1, 1999;
94(7):
2293 - 2300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujisaki, M. G. Berger, S. Rose-John, and C. J. Eaves
Rapid Differentiation of a Rare Subset of Adult Human Lin-CD34-CD38- Cells Stimulated by Multiple Growth Factors In Vitro
Blood,
September 15, 1999;
94(6):
1926 - 1932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Holyoake, X. Jiang, C. Eaves, and A. Eaves
Isolation of a Highly Quiescent Subpopulation of Primitive Leukemic Cells in Chronic Myeloid Leukemia
Blood,
September 15, 1999;
94(6):
2056 - 2064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Ailles, B. Gerhard, H. Kawagoe, and D. E. Hogge
Growth Characteristics of Acute Myelogenous Leukemia Progenitors That Initiate Malignant Hematopoiesis in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Blood,
September 1, 1999;
94(5):
1761 - 1772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bennaceur-Griscelli, C. Tourino, B. Izac, W. Vainchenker, and L. Coulombel
Murine Stromal Cells Counteract the Loss of Long-Term Culture-Initiating Cell Potential Induced by Cytokines in CD34+CD38low/neg Human Bone Marrow Cells
Blood,
July 15, 1999;
94(2):
529 - 538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aiuti, L. Turchetto, M. Cota, A. Cipponi, A. Brambilla, C. Arcelloni, R. Paroni, E. Vicenzi, C. Bordignon, and G. Poli
Human CD34+ Cells Express CXCR4 and Its Ligand Stromal Cell-Derived Factor-1. Implications for Infection by T-Cell Tropic Human Immunodeficiency Virus
Blood,
July 1, 1999;
94(1):
62 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Cashman and C. J. Eaves
Human Growth Factor-Enhanced Regeneration of Transplantable Human Hematopoietic Stem Cells in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Blood,
January 15, 1999;
93(2):
481 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.D. Cashman, C.J. Eaves, A.H. Sarris, and A.C. Eaves
MCP-1, not MIP-1alpha , Is the Endogenous Chemokine That Cooperates With TGF-beta to Inhibit the Cycling of Primitive Normal but not Leukemic (CML) Progenitors in Long-Term Human Marrow Cultures
Blood,
October 1, 1998;
92(7):
2338 - 2344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Conneally, C.J. Eaves, and R.K. Humphries
Efficient Retroviral-Mediated Gene Transfer to Human Cord Blood Stem Cells With In Vivo Repopulating Potential
Blood,
May 1, 1998;
91(9):
3487 - 3493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.C.Y. Wang, T. Lapidot, J.D. Cashman, M. Doedens, L. Addy, D.R. Sutherland, R. Nayar, P. Laraya, M. Minden, A. Keating, et al.
High Level Engraftment of NOD/SCID Mice by Primitive Normal and Leukemic Hematopoietic Cells From Patients With Chronic Myeloid Leukemia in Chronic Phase
Blood,
April 1, 1998;
91(7):
2406 - 2414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Ailles, B. Gerhard, and D. E. Hogge
Detection and Characterization of Primitive Malignant and Normal Progenitors in Patients With Acute Myelogenous Leukemia Using Long-Term Coculture With Supportive Feeder Layers and Cytokines
Blood,
October 1, 1997;
90(7):
2555 - 2564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Conneally, J. Cashman, A. Petzer, and C. Eaves
Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
PNAS,
September 2, 1997;
94(18):
9836 - 9841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.L. Petzer, C.J. Eaves, M.J. Barnett, and A.C. Eaves
Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid Leukemia
Blood,
July 1, 1997;
90(1):
64 - 69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Cashman, T. Lapidot, J. C.Y. Wang, M. Doedens, L. D. Shultz, P. Lansdorp, J. E. Dick, and C. J. Eaves
Kinetic Evidence of the Regeneration of Multilineage Hematopoiesis From Primitive Cells in Normal Human Bone Marrow Transplanted Into Immunodeficient Mice
Blood,
June 15, 1997;
89(12):
4307 - 4316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Zandstra, E. Conneally, A. L. Petzer, J. M. Piret, and C. J. Eaves
Cytokine manipulation of primitive human hematopoietic cell self-renewal
PNAS,
April 29, 1997;
94(9):
4698 - 4703.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|